Nail Fungus Treatment, Causes, Toenail Fungus, Remedies & Medications



Medically reviewed by Joseph Palermo, DO; Board Certificates: Inner Medication/Geriatric Medication
REFERENCES:Baran, R., R.J. Hay, and J.I. Garduno. “Evaluate of Antifungal Remedy, Half II: Therapy Rationale, Together with Particular Affected person Populations.” J Dermatolog Deal with 19.3 (2008): 168-175.Brillowska-Dabrowska, A., S.S. Nielsen, H.V. Nielsen, and M.C. Arendrup. “Optimized 5-Hour
Multiplex PCR Check for the Detection of Tinea Unguium: Efficiency in a Routine PCR
Laboratory.”
Med Mycol. 48.6 Sept. 2010: 828-831.Bristow, I.R., and M.C. Spruce. “Fungal Foot An infection, Cellulitis and Diabetes: A Evaluate.” Diabet Med 26 (2009): 548.de Berker, D. “Medical Apply. Fungal Nail Illness.” N Engl J Med. 360.20 Could 14, 2009: 2108-2116.Derby, R., P. Rohal, C. Jackson, et al. “Novel Therapy of Onychomycosis Utilizing Over-the-Counter Mentholated Ointment: A Medical Case Sequence.” J Am Board Fam Med 24 (2011): 69.Gaburri, D., J.M. Chebli, A. Zanine, A.C. Gamonal, and P.D. Gaburri. “Onychomycosis in
Inflammatory Bowel Ailments.”
J Eur Acad Dermatol Venereol. 22.7 JulY 2008: 807-812.Garcia-Doval, I., et al. “Medical Analysis of Toenail Onychomycosis Is Attainable in
Some Sufferers: Cross-sectional Diagnostic Examine and Growth of a Diagnostic
Rule.”
Br J Dermatol. 163.4 Oct. 2010: 743-751.Ginarte, M., Garcia-Doval, I., et al. “Observer Settlement in Toenail Issues:
Implications for Analysis and Medical Analysis.”
Br J Dermatol. 160.6 June 2009: 1315-1317.Gupta, A.Ok., L.E. Lynch, N. Kogan, and E.A. Cooper. “The Use of an Intermittent
Terbinafine Routine for the Therapy of Dermatophyte Toenail Onychomycosis.”
J Eur Acad Dermatol Venereol. 23.3 Mar. 2009: 256-262.Kondori, N., A.L. Abrahamsson, N. Ataollahy, and C. Wennerås. “Comparability of a
New Business Check, Dermatophyte-PCR Package, With Typical Strategies for Speedy Detection and
Identification of Trichophyton rubrum in Nail Specimens.” Med Mycol. 48.7 Nov. 2010: 1005-1008.Litz, C.E., and R.Z. Cavagnolo. “Polymerase Chain Response within the Analysis of Onychomycosis:
A Massive, Single-Institute Examine.” Br J Dermatol. 163.3 Sept. 2010: 511-514.Nair, A.B., S.R. Vaka, S.M. Sammeta, H.D. Kim, P.M. Friden, B. Chakraborty, and S.N. Murthy. “Trans-ungual
Iontophoretic Supply of Terbinafine.”
J Pharm Sci. 98.5 Could 2009: 1788-1796.Shemer, A., B. Davidovici, M.H. Grunwald, H. Trau, and B. Amichai. “Comparative
Examine of Nail Sampling Methods in Onychomycosis.”
J Dermatol. 36.7 Jul7 2009: 410-414.Shemer, A., H. Trau, B. Davidovici, M.H. Grunwald, and B. Amichai. “Onychomycosis in
Psoriatic Sufferers – Rationalization of Systemic Therapy.”
Mycoses. 53.4 July 2010: 340-343.Sigurgeirsson, B., J.H. Olafsson, J.T. Steinsson, N. Kerrouche, and F. Sidou. “Efficacy of
Amorolfine Nail Lacquer for the Prophylaxis of Onychomycosis Over 3 Years.”
J Eur Acad Dermatol Venereol. 24.8 Aug. 2010: 910-915.Smijs, T.G., and S. Pavel. “The Susceptibility of Dermatophytes to Photodynamic
Therapy With Particular Deal with Trichophyton rubrum.”
Photochem Photobiol. 87.1 Jan.-Feb. 2011: 2-13.Sotiriou, E., T. Koussidou-Eremonti, G. Chaidemenos, Z. Apalla, and D. Ioannides. “Photodynamic
Remedy for Distal and Lateral Subungual Toenail Onychomycosis Attributable to Trichophyton rubrum: Preliminary
Outcomes of a Single-Centre Open Trial.”
Acta Derm Venereol. 90.2 Mar. 2010: 216-217.Takahata, Y., M. Hiruma, Y. Shiraki, Y. Tokuhisa, T. Sugita, and M. Muto. “Therapy of
Dermatophyte Onychomycosis With Three Pulses of Terbinafine (500 mg Day for a Week).”
Mycoses. 52.1 Jan. 2009: 72-76.Thomas, J., et al. “Toenail Onychomycosis: An Vital International Illness Burden.”
J Clin Pharm Ther. 35.5 Oct. 2010: 497-519.Walling, H.W. “Subclinical Onychomycosis Is Related With Tinea Pedis.” Br J Dermatol. 161.4 Oct. 2009: 746-749.